Mace Security International, Inc. MACE
Set alert
0.02 +0.02 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.04M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
- Earnings
- Sep 30, 2024
2Y chart
Events in this range
- May 23, 2023Earnings: —; estimate 0; surprise —%
- Aug 14, 2023Earnings: —; estimate 0; surprise —%
- Nov 14, 2023Earnings: —; estimate 0; surprise —%
- Apr 1, 2024Earnings: —; estimate 0; surprise —%
- May 15, 2024Earnings: —; estimate 0; surprise —%
- Sep 30, 2024Earnings: —; estimate 0; surprise —%
Signals (97)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Dec 2, 2024 | 1 year ago |
| MACD: Buy Signal | Oct 16, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 8, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 29, 2024 | 2 years ago |
| SMA: Bearish | Aug 12, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 12, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 9, 2024 | 2 years ago |
| SMA: Bullish | Jul 30, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 24, 2024 | 2 years ago |
| SMA: Bearish | Jul 17, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 26, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 25, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 21, 2024 | 2 years ago |
| RSI: Overbought | Jun 11, 2024 | 2 years ago |
| SMA: Bullish | Jun 4, 2024 | 2 years ago |
| SMA: Bullish | Jun 4, 2024 | 2 years ago |
| RSI: Overbought | Jun 4, 2024 | 2 years ago |
| SMA: Bearish | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | May 30, 2024 | 2 years ago |
| MACD: Buy Signal | May 30, 2024 | 2 years ago |
| SMA: Bearish | May 17, 2024 | 2 years ago |
| SMA: Bullish | May 15, 2024 | 2 years ago |
| SMA: Bearish | May 14, 2024 | 2 years ago |
| MACD: Sell Signal | May 10, 2024 | 2 years ago |
| MACD: Buy Signal | May 9, 2024 | 2 years ago |
| MACD: Sell Signal | May 6, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 19, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 18, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 17, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 16, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 15, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 12, 2024 | 2 years ago |
| SMA: Bullish | Apr 11, 2024 | 2 years ago |
| SMA: Bearish | Apr 10, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 10, 2024 | 2 years ago |
| SMA: Bullish | Mar 27, 2024 | 2 years ago |
| SMA: Bearish | Mar 26, 2024 | 2 years ago |
| SMA: Bullish | Mar 21, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 21, 2024 | 2 years ago |
| SMA: Bearish | Mar 20, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 20, 2024 | 2 years ago |
| SMA: Bullish | Mar 19, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 19, 2024 | 2 years ago |
| SMA: Bearish | Mar 18, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 18, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 14, 2024 | 2 years ago |
| SMA: Bullish | Mar 13, 2024 | 2 years ago |
| SMA: Bearish | Mar 11, 2024 | 2 years ago |
| SMA: Bullish | Mar 7, 2024 | 2 years ago |
| SMA: Bearish | Feb 21, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 21, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 20, 2024 | 2 years ago |
| SMA: Bullish | Feb 16, 2024 | 2 years ago |
| SMA: Bearish | Feb 13, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 13, 2024 | 2 years ago |
| SMA: Bullish | Feb 7, 2024 | 2 years ago |
| SMA: Bearish | Feb 6, 2024 | 2 years ago |
| SMA: Bullish | Jan 26, 2024 | 2 years ago |
| SMA: Bearish | Jan 24, 2024 | 2 years ago |
| SMA: Bullish | Jan 23, 2024 | 2 years ago |
| SMA: Bearish | Jan 22, 2024 | 2 years ago |
| SMA: Bullish | Jan 19, 2024 | 2 years ago |
| MACD: Buy Signal | Nov 22, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 15, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 1, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 30, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 24, 2023 | 3 years ago |
| SMA: Bearish | Oct 3, 2023 | 3 years ago |
| SMA: Bullish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Sep 20, 2023 | 3 years ago |
| SMA: Bullish | Sep 19, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 30, 2023 | 3 years ago |
| RSI: Overbought | Aug 15, 2023 | 3 years ago |
| SMA: Bullish | Jul 28, 2023 | 3 years ago |
| SMA: Bearish | Jul 19, 2023 | 3 years ago |
| SMA: Bullish | Jul 18, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 29, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 28, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 5, 2023 | 3 years ago |
| RSI: Oversold | May 15, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 24, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 19, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 5, 2023 | 3 years ago |
| SMA: Bearish | Mar 30, 2023 | 3 years ago |
| SMA: Bullish | Mar 28, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 20, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 16, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 15, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 14, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 13, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 8, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 7, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 6, 2023 | 3 years ago |
Next earnings
Sep 30, 2024
Expected Sep 30, 2024. Consensus EPS estimate 0.00.
Financials — quick view
MACE Revenue — quarterly 6.14M
MACE Net income — quarterly -4.89M
MACE EPS — quarterly -0.31
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 23, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
News
- ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
- Head to Head Analysis: Mace Security International (OTCMKTS:MACE) versus XCF Global Capital (NASDAQ:SAFX)
- Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagliflozin to Reduce Major Adverse Cardiovascular Events (MACE)
- Mace(R) Security International, Inc. Announces Completion of Going Private Merger with W Electric Intermediate Holdings, LLC
- Mace(R) Security International, Inc. Announces Stockholder Approval of Merger with W Electric Intermediate Holdings, LLC
- Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Preliminary 3Q24 Financial Results and Notification of Late Filing
- Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Postponement of Annual Meeting of Shareholders
- Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Agreement and Plan of Merger
- Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces 2Q24 Financial Results
- Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Additional Unsecured Subordinated Funding
Your note
Sign in to keep a note on MACE — it syncs with the Stock Master app.